Trials / Completed
CompletedNCT02273947
Food Effect Study With BMS-955176
An Open-Label, Randomized, Crossover Adaptive Design Study to Assess the Effect of Food on the Pharmacokinetics of BMS-955176 Administered as a Micronized Crystalline Tablet in Healthy Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 12 (actual)
- Sponsor
- ViiV Healthcare · Industry
- Sex
- All
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to assess the impact of a light meal, a standard meal, and a high fat meal on the PK of BMS-955176 MC tablet at a dose of 180 mg, relative to fasted conditions.
Detailed description
Primary Purpose Other: This study will assess the impact of a light meal, a standard meal, and a high fat meal on the pharmacokinetics (PK) of BMS-955176 micronized crystalline (MC) tablet at a dose of 180 mg relative to fasted conditions.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | BMS-955176 | Single dose by mouth for each treatment specified |
Timeline
- Start date
- 2014-10-23
- Primary completion
- 2016-08-15
- Completion
- 2016-08-15
- First posted
- 2014-10-24
- Last updated
- 2017-04-17
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT02273947. Inclusion in this directory is not an endorsement.